🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this laboratory research study is to learn if interrupting a pa...
Status
Recruiting
Location
The University of Texas MD Anderson Cancer Center
Start Date
2024-11-20
Trial ID
NCT06639854
Treatments Being Tested
The purpose of this study is to compare the effects, good and bad, of two w...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2008-12-10
Trial ID
NCT00807599
Treatments Being Tested
Osteoporotic fractures are a key health problem in older men. Although ther...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2019-07-01
Trial ID
NCT03994172
Primary Objective: The primary objective of this study is to assess the to...
Status
Terminated
Location
CHU Hôpital Sud
Start Date
2020-02-11
Trial ID
NCT04107675
Treatments Being Tested
The purpose of the study is to compare the pharmacokinetics (what a medicat...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01986491
Depression is a disease that endangers the physical and mental health of al...
Status
Unknown
Location
Shanghai Mental Health Center
Start Date
2023-12-01
Trial ID
NCT05818735
Treatments Being Tested
Insomnia is a disorder characterized by difficulties in falling asleep, mai...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-01
Trial ID
NCT06258226
Treatments Being Tested
The purpose of this research study is to: * 1\) Test the safety and tolera...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-13
Trial ID
NCT01453491
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of a food-source...
Status
Unknown
Location
Integrative Health Technologies
Start Date
2013-07
Trial ID
NCT01890889
This is an open-label, crossover, randomized, single dose, three treatments...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-31
Trial ID
NCT02498288